Stock Events

Stock Events

Takeda Pharmaceutical 

$36.00
1201
+$1.99+5.87% Monday 17:16

Statistics

Day High
34
Day Low
34
52W High
39.2
52W Low
26.33
Volume
100
Avg. Volume
13,075
Mkt Cap
114.95B
P/E Ratio
-
Dividend Yield
1.78%
Dividend
0.64

Upcoming

Dividends

1.78%Dividend Yield
Jun 26
$0.62
Dec 25
$0.64
Jun 25
$0.68
Dec 24
$0.65
Jun 24
$0.58
10Y Growth
-2.39%
5Y Growth
-5.49%
3Y Growth
-0.69%
1Y Growth
-5.33%

Earnings

29OctExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-0.44
-0.11
0.22
0.55
Expected EPS
0.2872245
Actual EPS
N/A

Financials

2.48%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
31.27BRevenue
775.41MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TKPHF. It's not an investment recommendation.
Japan Tobacco
328
2914.TSE
Mitsubishi UFJ Financial Group
288
8306.TSE
NTT
242
9432.TSE
Mitsubishi HC Capital
227
8593.TSE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap159.99B
Pfizer is a global pharmaceutical company that competes with Takeda in various therapeutic areas, including oncology and immunology.
Novartis
NVS
Mkt Cap301.95B
Novartis is a multinational pharmaceutical company that competes directly with Takeda in areas such as cardiovascular, oncology, and neuroscience.
Merck
MRK
Mkt Cap376.37B
Merck is known for its strong presence in the pharmaceutical industry, competing with Takeda in oncology, vaccines, and infectious diseases.
Johnson & Johnson
JNJ
Mkt Cap651.25B
Johnson & Johnson, through its pharmaceutical segment Janssen, competes with Takeda in immunology, neuroscience, and oncology.
Abbvie
ABBV
Mkt Cap468.22B
AbbVie competes with Takeda in the fields of immunology and oncology, with both companies having significant investments in research and development.
GSK
GSK
Mkt Cap104.97B
GlaxoSmithKline competes with Takeda in respiratory, vaccines, and infectious disease, with a strong focus on research and development.
Sanofi
SNY
Mkt Cap109.86B
Sanofi competes with Takeda in areas such as immunology, oncology, and rare diseases, with a broad portfolio of products.
Bristol-Myers Squibb
BMY
Mkt Cap136.88B
Bristol Myers Squibb competes with Takeda in oncology and cardiovascular diseases, with both companies focusing on innovative treatments.
Roche
RHHBY
Mkt Cap334.28B
Roche, through its pharmaceutical division, competes with Takeda in oncology, immunology, and infectious diseases, with a strong emphasis on biologics.
Astrazeneca
AZN
Mkt Cap257.42B
AstraZeneca competes with Takeda in several key areas including oncology, cardiovascular, and respiratory diseases, with a focus on innovation and targeted therapies.

About

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
Show more...
CEO
Julie So-Young Kim
Employees
47029
Country
Japan
ISIN
JP3463000004
WKN
000853849

Listings

MX
MX
TAKN.MX
STU
DE
TKD.STU
SA
BR
TAKP34.SA
MU
DE
TKDA.MU

0 Comments

Share your thoughts

FAQ

What is Takeda Pharmaceutical stock price today?▼
The current price of TKPHF is $36.00 USD — it has increased by +5.87% in the past 24 hours. Watch Takeda Pharmaceutical stock price performance more closely on the chart.
What is Takeda Pharmaceutical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Takeda Pharmaceutical stocks are traded under the ticker TKPHF.
Is Takeda Pharmaceutical stock price growing?▼
TKPHF stock has risen by +5.87% compared to the previous week, the month change is a +10.41% rise, over the last year Takeda Pharmaceutical has showed a +16.11% increase.
What is Takeda Pharmaceutical market cap?▼
Today Takeda Pharmaceutical has the market capitalization of 114.95B
When is the next Takeda Pharmaceutical earnings date?▼
Takeda Pharmaceutical is going to release the next earnings report on October 29, 2026.
What were Takeda Pharmaceutical earnings last quarter?▼
TKPHF earnings for the last quarter are 0.44 USD per share, whereas the estimation was 0.33 USD resulting in a +31.76% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Takeda Pharmaceutical revenue for the last year?▼
Takeda Pharmaceutical revenue for the last year amounts to 31.27B USD.
What is Takeda Pharmaceutical net income for the last year?▼
TKPHF net income for the last year is 775.41M USD.
Does Takeda Pharmaceutical pay dividends?▼
Yes, TKPHF dividends are paid semi-annual. The last dividend per share was 0.62 USD. As of today, Dividend Yield (FWD)% is 1.78%.
How many employees does Takeda Pharmaceutical have?▼
As of August 25, 2026, the company has 47,029 employees.
In which sector is Takeda Pharmaceutical located?▼
Takeda Pharmaceutical operates in the Health & Wellness sector.
When did Takeda Pharmaceutical complete a stock split?▼
Takeda Pharmaceutical has not had any recent stock splits.
Where is Takeda Pharmaceutical headquartered?▼
Takeda Pharmaceutical is headquartered in Tokyo, Japan.